Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
safe harbor regulations
safety ephedra Patient Safety and Quality Improvement Act of 2005 FDA Safety and Innovation Act of 2012 postmarket drug safety information for patients and providers
sale of pharmacy
See Substance Abuse and Mental Health Services Administration (SAMHSA) Purpose of a Controlled Substance Prescription See Substance Abuse and Mental Health Services Administration (SAMHSA) Opioid Treatment Programs References Treatment of Addicts Outside of OTPs
samples, regulation of
Sandoz Pharmaceuticals
Schaubman v. Blum (1980)
schedule I drugs distribution between registrants Schedule I (Drugs and Other Substances)
schedule III drugs Dispensing of Schedule III, IV, and V Controlled Substances labeling of refills electronic refill records partial filling of Schedule III (Drugs and Other Substances)
schedule IV drugs Dispensing of Schedule III, IV, and V Controlled Substances Schedule V (Drugs and Other Substances)
schedule V drugs Dispensing of Schedule III, IV, and V Controlled Substances Schedule V (Drugs and Other Substances)
scheduling authority
Schlieter v. Carlos
Department of Professional Regulation (1992) Schram v. Department of Professional Regulation Grounds for Discipline
scope of practice expanded responsibilities, liability and united states V. hayes (1979) - United States V. Hayes pharmacy practice, state definition of walgreen co. V. selcke (1992) - Walgreen Co. V. Selcke
screening prescriptions
Section 402A, Restatement of Torts
section 505(b)(2) applications
security requirements e-prescribing registration application HIPAA Security Requirements
See v. City of Seattle (1967)
self-administration of drugs
Senate and the House of Representatives
Sender v. Department of Professional Regulation (1994)
Serialized National Drug Code (sNDC)
Shaw v. Delta Airlines (1983)
Sherman Antitrust Act (1890) efforts to influence government action joint ventures monopoly power preferred provider organizations purchasing cooperatives third-party prescription programs concerted activity exclusive contracts market power per se violations, types of prescription benefit managers (PBMs) rule of reason and per se rule
Sinclair, Upton
Skilstaf Inc. v. CVS Caremark Corp et al. (2009)
See scheduled listed chemical products (SLCP) The Combat Methamphetamine Epidemic Act of 2005 and the Methamphetamine Prevention Act of 2008 See scheduled listed chemical products (SLCP)
See supplemental new drug application (SNDA) Approved Drugs for Off-Label (Unlabeled) Indications Professional Practice Considerations Switch of Prescription Drugs to Over-the-Counter Drugs Prescription Drug Marketing Act of 1987 See supplemental new drug application (SNDA)